Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

Background: Vaccines comprising recombinant subunit proteins are well-suited to low-cost and high-volume production for global use. The design of manufacturing processes to produce subunit vaccines depends, however, on the inherent biophysical traits presented by an individual antigen of interest. N...

Full description

Bibliographic Details
Main Authors: Dalvie, Neil C., Brady, Joseph R., Crowell, Laura E., Tracey, Mary Kate, Biedermann, Andrew M., Kaur, Kawaljit, Hickey, John M., Kristensen II, D. Lee, Bonnyman, Alexandra D., Rodriguez-Aponte, Sergio A., Whittaker, Charles A., Bok, Marina, Vega, Celina Guadalupe, Mukhopadhyay, Tarit K., Joshi, Sangeeta B., Volkin, David B., Parreño, Gladys, Love, Kerry R., Love, J. Christopher
Format: info:ar-repo/semantics/artículo
Language:Inglés
Published: BMC 2021
Subjects:
Online Access:http://hdl.handle.net/20.500.12123/10760
https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-021-01583-6
https://doi.org/10.1186/s12934-021-01583-6

Similar Items: Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus